Scarica l'app Stockscreener
1.11
0.91%
0.01
Dopo l'orario di chiusura:
1.09
-0.02
-1.80%
Lucid Diagnostics Inc Borsa (LUCD) Ultime notizie
What drives Lucid Diagnostics Inc. stock priceHigh-yield growth strategies - PrintWeekIndia
What analysts say about Lucid Diagnostics Inc. stockFree Consultation - PrintWeekIndia
Is Lucid Diagnostics Inc. a good long term investmentStrong return on assets - jammulinksnews.com
Lucid Diagnostics Inc. Stock Analysis and ForecastBreakthrough capital growth - jammulinksnews.com
Immunovia's Strategic Hiring of Natalie Carfora: A Catalyst for Reimbursement Success and Market Expansion of PancreaSure - AInvest
Immunovia Names Natalie Carfora VP of Market Access and Reimbursement Ahead of PancreaSure Launch - AInvest
[New] Lucid Stock Price Prediction 2024, 2025 To 2050 - Exla Resources
Lucid says meeting scheduled to determine Medicare coverage for cancer test - MSN
LUCD’s 2025 Market Dance: Up 26.00% – Time to Invest? - investchronicle.com
what makes lucid diagnostics inc. stock price move sharply3x Growth Potential - Newser
Esophageal Cancer Detection Revolution: Lucid's Medicare Milestone and Its Market Impact - AInvest
Lucid says AdCom meeting set to determine cancer test coverage - Seeking Alpha
Lucid Diagnostics Inc. shares fall 5.98% intraday as MolDX convenes expert medical panel on Medicare. - AInvest
MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA Test - StreetInsider
How Lucid Diagnostics Inc. stock performs during market volatilityRisk Managed Trading Strategy - Newser
What makes Lucid Diagnostics Inc. stock price move sharplyInvestor Favorite Picks - Newser
Why Lucid Diagnostics Inc. stock attracts strong analyst attentionRisk Aware High Growth Picks - Newser
Brokerages Set Lucid Diagnostics Inc. (NASDAQ:LUCD) Price Target at $3.55 - Defense World
Lucid Diagnostics Inc.(NasdaqCM: LUCD) added to Russell Small Cap Comp Growth Index - MarketScreener
Lucid Diagnostics Inc.(NasdaqCM: LUCD) added to Russell 3000 Index - MarketScreener
Is Lucid Diagnostics, Inc. technically bullish or bearish? - MarketsMojo
Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test - BioSpace
Lucid Diagnostics Holds Annual Stockholders Meeting - TipRanks
Leading California Hospital Network Launches Revolutionary 3-Minute Cancer Detection Test from Lucid Diagnostics - Stock Titan
119,887 Shares in Lucid Diagnostics Inc. (NASDAQ:LUCD) Acquired by Citadel Advisors LLC - Defense World
Ascendiant Capital Markets Issues Positive Forecast for Lucid Diagnostics (NASDAQ:LUCD) Stock Price - Defense World
Ascendiant Capital raises Lucid Diagnostics stock price target to $7.75 By Investing.com - Investing.com South Africa
Ascendiant Capital raises Lucid Diagnostics stock price target to $7.75 - Investing.com Australia
Lucid Diagnostics (LUCD) Stock Maintained at Buy by Ascendiant Capital | LUCD Stock News - GuruFocus
Lucid Diagnostics (LUCD) Target Price Increased by Ascendiant | - GuruFocus
Lucid Diagnostics Files For Offering Of 36 Million Shares Of Common Stock - MarketScreener
Pavmed's Veris Health Signs Long-Term Partnership Deal With Ohio State University Hospital - marketscreener.com
SAIC, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Lucid Diagnostics Enters $25M Sales Agreement - TipRanks
Lucid Diagnostics joins Russell 2000 and 3000 indexes - Mugglehead Magazine
Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes - The Malaysian Reserve
Lucid Diagnostics to Join Russell 2000, Russell 3000 Indexes - marketscreener.com
Lucid Diagnostics to join Russell 2000 and Russell 3000 indexes By Investing.com - Investing.com South Africa
1.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):